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Background:Actinomycosis is a chronic,supporative pseudotu-
moral disease caused by an anaerobic grampositive organismmost
frequently Actinomyces israelii. Isolated cases of abdominal acti-
nomycosis (AA) are usually reported in Literature. However, due
to that is an uncommom abdominal infection,there are not large
series of patients with this diagnosis. Main objective is assessing
the frequency of AA, characterizing patients diagnosedwith AA and
stablishing the risk factors for appendiceal actinomycosis(APA).
Methods & Materials: Prospective cohort study of all
patients diagnosed of AA in the University Hospital Marques de
Valdecilla (Santander-Cantabria), from1st of January,2003 to31st of
October,2013 was analyzed. We reviewed clinical features, micro-
biologic data, treatments, and outcome of all AA cases reported in
the literature between January 1, 1995, and September 30, 2013, to
provide a current characterization of the syndrome.
Results: A total of 13 (61,5% men) patients diagnosed with
AA were collected. Mean age at diagnosis was 48.6+/-22.9 years.
Most of them proceeded from General Surgery(76.9%), General
Medicine(15.4%) and Nefrology departments (7.7%). None needed
admission in ICU. Patients have the following antecedents: solid
organ cancer (23.1%), hollow viscera perforation (7.7%), solid organ
transplant recipient (7.7%), recient abdominal surgery in lastmonth
(cholecystectomy) in 7.7%, HIV infection(7.7%). No dental manip-
ulations were found. Abdominal-CT stablished the presumptive
diagnosis in 46.2% of the cases. Themost frequent abdominal site of
AAwas the appendix (30.8%). Surgerywas perfomed in all patients.
Mean values CRP, Hemoglobin and Hematocrit at the moment of
diagnosis are7.4+/-7.2mg/dl, 11.9+/-2.3 g/dl and35.4+/-6.2 respec-
tively. Stay in-hospital was 14.85+/-17.1 days. Antibiotheraphy
was recorded in 38.5% patients, each of them received antibiotics
(penicillins). No reinterventions or deaths were recorded during
follow-up. Risk factors for APA were: no antecedents of cancer
(OR4.9,p =0.034) and wrong previous diagnosis of appendicitis
(OR7.6,p =0.006).
Conclusion: Dued to the rarety of this infections, only case
reports are reported in the literature.We present the largest serie
of patients diagnosed of AA. Morbility was found in 53.9% patients,
mostly carcinomas. Penicillins was the preferred treatment. Risk
factors for PAP are: no antecedents of carcinomas (p=0.034) and
previous uncorrect diagnosis (p =0.006). No deaths were found.
http://dx.doi.org/10.1016/j.ijid.2014.03.1162
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Background: The NDoH endorsed the GXP for the diagnosis of
TB in 2011. A positive GXP result is followed by smear for notiﬁca-
tion purposes. Resistance to rifampicin is followed by culture and
DST. Isoniazid resistance is diagnosed post DST testing.
Hain LPA was endorsed in 2008 for smear positive samples. The
version 2, used in smear negative samples, gives both rifampicin
and isoniazid susceptibilities and has a built in smear at no addi-
tional cost.
Hain LPA v2 is cheaper than the GXP and expedites the transfer
of patients to an MDRTB facility. GXP rifampicin resistant patients
pose an infection prevention and control nightmare with regards
to isolation of patients and prolonged duration of hospital stay.
We ran a laboratory validation comparing the GXP to the Hain
LPA v2 on smear negative samples at CHBAH.
Methods & Materials: With the permission of management
at CHBAH, a mini laboratory validation was run from the 5th
- 23rd November 2012. 2 sputum samples were obtained from
newly admitted medical patients who were TB suspects. Smear
microscopy was done on 1 sample followed by the Hain LPA. The
second sample was tested with the GXP.
Results:86 sputumsampleswere submitted for LPA. 31 samples
had a concurrent GXP. 1 sample was deemed invalid. Therefore 30
samples were assessed for the validation. 3 were positive on the
GXP and LPA v2. 25 (83%) were negative on both. There were 2
discrepant results where the LPAwas positivewith a negative GXP.
One patient was already on TB treatment and the second was a
newly diagnosed patient. The differences could also be attributed
to the limits of detection of the 2 diagnostic tests (GXP 131cfu/ml
and LPA 100 - 150cfu/ml). The sensitivity was 100% and speciﬁcity
was 92.6%.
Conclusion:Oncomparison the speciﬁcity is inkeepingwith the
reported literature. However the sensitivity needs to be interpreted
with caution due to the small sample size. Since themini validation
showed promise with decreasing duration of hospital stay as well
as cost effectiveness, the validation was extended from March to
November 2013. Results of which are pending.
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